Substance use & recovery

The Six Questions That Decide Where You Get Treated

Save

When a clinician assesses someone for addiction treatment, they are really answering six questions at once. Each one looks at a different part of the person's life and health, and the answers together — not any single one — decide whether outpatient, a day program, or residential care fits. Here is what each of the six dimensions asks, and why no single answer settles the placement on its own.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What are the six ASAM dimensions?

The six dimensions are the assessment framework at the heart of the ASAM criteria — six areas of a person's life and health that a clinician reviews to match them to the right level of care rather than a fixed program 1. They are: intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse and continued-use potential, and the recovery environment. No single dimension decides placement. The assessment weighs all six together, which is why two people using the same substance can land in very different levels of care.

Placement is set by all six dimensions together, not by the drug someone used or a program's default length.

Dimension 1 — intoxication and withdrawal potential

The first dimension asks how someone is right now and what stopping will do to their body — because for some substances, withdrawal itself is the emergency. Alcohol withdrawal can progress to seizures and delirium tremens, a state that carries a real risk of death when it is not treated, and it is managed under medical supervision rather than at home 2. This is why this dimension often drives the whole decision: if withdrawal could be dangerous, the person needs a setting with medical monitoring before anything else is considered. This is also the dimension covered in depth on the ASAM dimension 1 page.

Dimension 2 — biomedical conditions and complications

The second dimension looks at the rest of a person's physical health — the medical conditions that ride alongside the substance use and can change what treatment is safe. Pregnancy, diabetes, liver disease, heart problems, chronic pain, an untreated infection: any of these can raise the level of care a person needs, because treatment has to be delivered somewhere those conditions can also be watched. A stable, healthy body may make a lighter setting reasonable; a fragile one may require closer medical support even when the addiction itself looks manageable. The framework treats the person, not just the diagnosis 1.

Dimension 3 — emotional, behavioral, and cognitive conditions

The third dimension asks about mental health and thinking — depression, anxiety, trauma, psychosis, suicidal thoughts, or cognitive difficulties that co-occur with the substance use. These are common, and they matter for placement because a program has to be able to treat what is actually present. Active suicidal thinking or an unstable psychiatric condition can raise the level of care sharply, since the setting must be safe for that too. Treating the addiction while ignoring a co-occurring mental-health condition tends to fail; this dimension is how the assessment makes sure both are accounted for from the start 1.

Dimension 4 — readiness to change

The fourth dimension asks where the person actually is in wanting to change — not as a test to pass, but as information that shapes the plan. Someone certain they want to stop and someone ambivalent about it both belong in treatment; they may simply belong in different kinds. Recovery is understood as a process of change toward better health and self-direction, and it is reached by many pathways rather than one 3. Low readiness is not a reason to turn a person away. It is a reason to meet them where they are and build motivation as part of the care, not as a precondition for it.

Dimension 5 — relapse, continued use, and continued problem potential

The fifth dimension asks how likely someone is to keep using or to return to use, and how much structure they need to interrupt that pattern. A long history of relapse right after leaving treatment, strong cravings, or an inability to stay abstinent between sessions can all point toward a more intensive level of care. Ongoing use is not treated as a moral failing or grounds for withholding help: the opioid-use-disorder guideline is explicit that no medication should be withheld because someone is still using other substances 4. This dimension shapes how much support the plan builds in, not whether the person deserves it.

Dimension 6 — recovery and living environment

The sixth dimension asks what a person is going home to — the people, housing, and daily surroundings that will either support recovery or undermine it. A stable home with supportive relationships can make a lighter level of care workable; a chaotic, unsafe, or using household can make even a strong treatment plan hard to hold onto. Recovery is built on more than abstinence, resting on health, home, purpose, and community 3. When the environment offers little of that, the assessment may lean toward a setting that provides structure the person's own surroundings cannot.

How the six add up to a placement

The dimensions are scored together, and the highest area of need tends to pull the placement — a single dangerous withdrawal risk can outweigh five stable dimensions. Quality addiction treatment spans a range of intensities, from outpatient through residential, and the right one is chosen by assessment rather than by a default program 5. This is what level of care matching means in practice: the same six questions, asked in the same order, produce a defensible answer about whether inpatient vs outpatient rehab, a day program, or something in between fits. A level of care assessment is where those six answers are gathered, and the ASAM levels of care are what they map onto.

A more intensive placement is not a judgment about willpower. It is the assessment saying this person needs more support to be safe right now.

Common questions

They are: (1) intoxication and withdrawal potential, (2) biomedical conditions and complications, (3) emotional, behavioral, and cognitive conditions, (4) readiness to change, (5) relapse and continued-use potential, and (6) the recovery and living environment. A clinician assesses all six to match a person to the right level of care rather than a fixed program.

None ranks above the others by default, but the highest area of need usually drives the placement. Dimension 1, withdrawal potential, often dominates because dangerous alcohol or benzodiazepine withdrawal requires medical monitoring before anything else. In another person, an unstable mental-health condition or an unsafe home might be the deciding factor instead.

No. Readiness to change is dimension 4, and it shapes the kind of treatment offered rather than whether treatment is offered at all. Ambivalence is normal and expected. Good care meets a person where they are and builds motivation as part of the work, instead of treating readiness as a precondition for getting help.

Because the drug is only part of the picture. The six dimensions weigh physical health, mental health, readiness, relapse history, and home environment alongside withdrawal risk. Two people using the same substance can differ on all five of those, so the assessment can reasonably place them in different levels of care.

A trained clinician — often an addiction counselor, nurse, physician, or other licensed professional — conducts a structured interview covering all six dimensions. It is meant to be a clinical judgment, not a sales tool. If a program decides your placement before anyone has assessed these dimensions, that is a reason for caution.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When the assessment can't wait

  • Shaking, sweating, a racing heart, fever, or confusion after cutting down on alcohol or benzodiazepines — possible delirium tremens
  • A past withdrawal seizure or episode of delirium tremens
  • Active thoughts of suicide or of not wanting to be alive
  • Slowed or stopped breathing, or someone who cannot be woken, after opioid or sedative use

If stopping alcohol or benzodiazepines brings on seizures, confusion, or hallucinations, call 911 or go to an emergency room — this is dimension 1 becoming an emergency. For thoughts of suicide, call or text 988. A formal assessment is important, but it comes after immediate safety.

This article is educational and does not replace a clinical assessment or personal medical advice. The right level of care should be decided with a qualified clinician who has evaluated the person's specific situation across all six dimensions.

References

  1. 1.American Society of Addiction Medicine (2024). The ASAM Criteria. American Society of Addiction Medicine (ASAM). linkThat ASAM defines a standardized, multidimensional assessment used to match a person to a level of care based on assessed need across the six dimensions rather than a fixed program.
  2. 2.StatPearls Publishing (NCBI Bookshelf) (2024). Alcohol Withdrawal Syndrome. StatPearls (NCBI Bookshelf), NIH National Library of Medicine. linkThat alcohol withdrawal can progress to seizures and delirium tremens, that delirium tremens carries a meaningful mortality risk if untreated, and that it is managed under medical supervision — the danger that dimension 1 exists to catch.
  3. 3.Substance Abuse and Mental Health Services Administration (2012). SAMHSA's Working Definition of Recovery. SAMHSA. linkThat recovery is a process of change toward improved health and self-direction built on the dimensions of health, home, purpose, and community, and that there are many pathways to it — informing the readiness and recovery-environment dimensions.
  4. 4.American Society of Addiction Medicine (2020). The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update. American Society of Addiction Medicine (ASAM). linkThat no medication for opioid use disorder should be withheld because a person is still using other substances — evidence that continued use is a reason to add support, not to withhold care, within dimension 5.
  5. 5.National Institute on Alcohol Abuse and Alcoholism (2024). Types of Alcohol Treatment — Alcohol Treatment Navigator. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. linkThat quality treatment spans levels of intensity — outpatient, intensive outpatient, residential, inpatient — chosen by assessment rather than by a default program.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy